Our NZMP SureStart™ team will be on the ground from 9th – 12th May 2018 in Geneva, Switzerland at one of the world’s leading paediatric events.
ESPGHAN’s aim is to promote the health of children, with special attention to the gastrointestinal tract, liver and nutritional status. The multi-professional organisation is a well-respected forum bringing clinicians, academics and industries together, where latest scientific findings can be shared.
This year, NZMP will be presenting for the first time new findings from 3 research studies on SureStart™ MFGM Lipids and SureStart™ LactoB 001 probiotic. The presentations will span across the following:
- Pregnancy study with MFGM complex lipids (MFGM Lipid100) – The first large study to show the impact of dietary supplementation with MFGM gangliosides and phospholipids in pregnancy.
- Infant study with MFGM complex lipids (MFGM Lipid100) for cognitive development – Supplementation with MFGM as a source of gangliosides and phospholipids in the first year of life and some measures of cognitive development at 6 and 12 months of age.
- Lactobacillus rhamnosus HN001 (LactoB 001) –The benefits of probiotic supplementation during infancy and effects later in childhood.
If you’re attending ESPGHAN this year, please visit our NZMP SureStart™ team at booth 41 to learn more.
To see more of what you can expect at ESPGHAN this year, visit: www.espghan.org